BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Staging
8 results:

  • 1. ADAM metallopeptidase with thrombospondin type 1 motif 16 is a potential marker for prognosis in clear cell renal cell carcinoma.
    Bai C; Chen DG
    Pathol Int; 2023 Jul; 73(7):297-305. PubMed ID: 37132990
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MCT1 expression is independently related to shorter cancer-specific survival in clear cell renal cell carcinoma.
    de Carvalho PA; Bonatelli M; Cordeiro MD; Coelho RF; Reis S; Srougi M; Nahas WC; Pinheiro C; Leite KRM
    Carcinogenesis; 2021 Dec; 42(12):1420-1427. PubMed ID: 34668521
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patient selection and technical aspects for laparoscopic nephrectomy in Wilms tumor.
    Schmidt A; Warmann SW; Urla C; Schaefer J; Fideler F; Fuchs J
    Surg Oncol; 2019 Jun; 29():14-19. PubMed ID: 31196478
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma.
    Zhang S; He J; Jia Z; Yan Z; Yang J
    Urol Oncol; 2018 May; 36(5):243.e9-243.e20. PubMed ID: 29503142
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Snail heterogeneity in clear cell renal cell carcinoma.
    Zaldumbide L; Erramuzpe A; Guarch R; Pulido R; Cortés JM; López JI
    BMC Cancer; 2016 Mar; 16():194. PubMed ID: 26951092
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.
    Jiang X; Kenerson H; Aicher L; Miyaoka R; Eary J; Bissler J; Yeung RS
    Am J Pathol; 2008 Jun; 172(6):1748-56. PubMed ID: 18511518
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Renal adenocarcinoma: 20 years of surgical experience, 1970-1990].
    De Giovanni M; Fanciullacci F; Casella F; Lombardi F; Zanollo A
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63(2):239-44. PubMed ID: 1830672
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.